Research.Patient.info
Venous Thromboembolism (VTE) research hub
2 indexed studies · 1 currently recruiting
- recruitingPHASE4
Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk
This study looks at whether a blood-thinning medicine called LMWH can prevent dangerous blood clots in new mothers who have a medium risk of getting them after childbirth. It compares taking the medicine for 6 weeks to not taking it.
France - ongoing, recruitingPhase II and Phase III (Integrated)
A multicenter, randomized, open-label, blinded endpoint evaluation, phase 3 study comparing the effect of abelacimab relative to apixaban on venous thromboembolism (VTE) recurrence and bleeding in patients with cancer associated VTE (ASTER)
This study looks at a new drug, abelacimab, compared to a standard drug, apixaban, for treating blood clots in veins (VTE) in people with cancer. The main goal is to see which drug is better at preventing new clots and causing less bleeding over six months.
Latvia · Ireland · Italy